Pharmaceutical Business Review
Return to: PBR Home | Companies

CASI Pharmaceuticals Inc

CASI Pharmaceuticals Inc
Suite 300
9620 Medical Center Drive
Rockville
United States of America
Phone: 1 240 8642600
Fax: 13-01-3152437
www.casipharmaceuticals.com

No. employees: 49
Turnover: 00.00 (US$m)
Financial year end: December

Company Overview

Top Competitors


Key Employees

Ken K. Ren, Ph.D.

Director, Chief Executive Officer, Executive Board

Wei-Wu He, Ph.D.

Chairman, Executive Board

James Huang

Director, Non Executive Board

Y. Alexander Wu, Ph.D.

Director, Non Executive Board

Franklin C. Salisbury, Jr.

Director, Non Executive Board

Rajesh C. Shrotriya, M.D.

Director, Non Executive Board

Quan Zhou, Ph.D.

Director, Non Executive Board

Cynthia Wong Hu

Secretary, Chief Operating Officer, General Counsel, Senior Management

Sara B. Capitelli

Vice President - Finance, Principal Accounting Officer, Senior Management

James E. Goldschmidt, Ph.D.

Senior Vice President - Business Development, Senior Management

Alexander A. Zukiwski, M.D.

Chief Medical Officer, Senior Management

Locations/Subsidiaries


Suite 300,
9620 Medical Center Drive,
Rockville,
Maryland,
United States of America
Phone: 1 240 8642600
Fax: 1 301 3152437

Beijing,
China

CASI (Beijing) Pharmaceuticals Inc

Suite B1215,
Fenglian Plaza,
Chaoyang,
Beijing,
China
Phone: 86 10 65086063
Fax: 86 10 65086063

Products/Services


Products:

  • Pipeline
  • ENMD-2076:
  • Fibrolamellar Carcinomas
  • Triple-Negative Breast Cancer
  • CASI-001:
  • Oncology
  • CASI-002:
  • Oncology
  • In-licensed Drug Candidates:
  • Marqibo:
  • Acute Lymphoblastic Leukemia
  • Evomela (melphalan) for injection:
  • Multiple Myeloma
  • Zevalin:
  • Non-Hodgkin’s Lymphoma